Gene · 1031
Papers2,553
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,553
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating plasma proteomes with genome-wide association data for causal protein identification in hepatocellular carcinoma: A bidirectional Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41578465 | PubTator, text mining | PubMed |
| Clinicopathologic and molecular spectrum of gastrointestinal stromal tumor (GIST) with NTRK fusion and marked response to larotrectinib in GIST with NTRK fusion: a case report. | Cell Oncol (Dordr) | 2026 | 41553644 | PubTator, text mining | PubMed |
| Large-scale analysis of chromosomal aberrations in uterine leiomyoma. | Am J Obstet Gynecol | 2026 | 41548634 | PubTator, text mining | PubMed |
| Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy. | Neurooncol Adv | 2026 | 41541220 | PubTator, text mining | PubMed |
| Multi-center multi-omics integration predicts individualized prognosis in medullary thyroid carcinoma. | Nat Commun | 2026 | 41535264 | PubTator, text mining | PubMed |
| Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH). | Blood | 2026 | 41481388 | PubTator, text mining | PubMed |
| Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection. | Blood Adv | 2026 | 41092482 | PubTator, text mining | PubMed |
| Redistribution of super-enhancers promotes malignancy in human hepatocellular carcinoma. | J Adv Res | 2026 | 40617410 | PubTator, text mining | PubMed |
| Potential antisense oligonucleotide targeting LINC00673 on proliferation and apoptosis in tongue squamous cell carcinoma. | J Taibah Univ Med Sci | 2025 | 41541836 | PubTator, text mining | PubMed |
| Exploring Genetic Markers for Cold-Heat Patterns: Integrating Traditional Medicine With Modern Genomic Research. | Genet Res (Camb) | 2025 | 41322252 | PubTator, text mining | PubMed |
| Inactivation of CDK4/6, CDK2, and ERK in G1-phase triggers differentiation commitment. | Commun Biol | 2025 | 41272295 | PubTator, text mining | PubMed |
| Interplay Between Type 2 Diabetes Susceptibility and Prostate Cancer Progression: Functional Insights into C2CD4A. | Diagnostics (Basel) | 2025 | 41226058 | PubTator, text mining | PubMed |
| A STAT1-GBP1 axis modulates epithelial proliferation in postpartum breast tissue by repressing CDKI expression. | Breast Cancer Res | 2025 | 40999477 | PubTator, text mining | PubMed |
| Reviving p18INK4c: Harnessing a tumor suppressor for cancer treatment. | Biochem Biophys Res Commun | 2025 | 40974910 | PubTator, text mining | PubMed |
| Machine learning-based identification of diagnostic and prognostic mitotic cell cycle genes in hepatocellular carcinoma. | PLoS One | 2025 | 40875626 | PubTator, text mining | PubMed |
| Systemic Sclerosis with Interstitial Lung Disease: Identification of Novel Immunogenetic Markers and Ethnic Specificity in Kazakh Patients. | Epidemiologia (Basel) | 2025 | 40843700 | PubTator, text mining | PubMed |
| "A novel approach to understanding the role of TCF3 mutations in childhood B-cell precursor acute lymphoblastic leukemia". | Transl Oncol | 2025 | 40811980 | PubTator, text mining | PubMed |
| A prognostic signature for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. | Sci Rep | 2025 | 40695981 | PubTator, text mining | PubMed |
| A Genomic Alteration in GATA3 Affects Treatment Responses With a CDK4/6 Inhibitor Collaborating With p18INK4C Expression in Advanced Breast Carcinoma. | Mod Pathol | 2025 | 40680849 | PubTator, text mining | PubMed |
| Correction: Absence of cyclin-dependent kinase inhibitor p27 or p18 increases efficiency of iPSC generation without induction of iPSC genomic instability. | Cell Death Dis | 2025 | 40419533 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1031/papers?page=2